Summary Product
Found 4 free book(s)
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eucurrent summary of product characteristics. The administration schedule must be carefully followed. If a planned dose of SARCLISA is missed, administer the dose as soon as possible and adjust the treatment schedule accordingly, maintaining the treatment interval. Dose adjustments No dose reduction of SARCLISA is recommended.
Storage Summary - Centers for Disease Control and …
www.cdc.govproduct-storage-and-dry-ice). 3. Review practices for working with dry ice in the Dry Ice ... Storage and Handling Summary, Storing Vaccine, Dry Ice Safety, Ancillary Supply Kit, Mixing Vaccine, Thermal Shipping Containers, Ultra Cold Freezers, Freezers, Refrigerators, Temperature Monitoring, Diluent, Mixed Vaccine, Disposal, Pfizer-BioNTech ...
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euSummary of the safety profile The overall safety of Vaxzevriais based on an analysis of pooled data from four clinical trials phase I/II, II/III and III conducted in the United Kingdom, Brazil, and South Africa,and of data from an additionalphase III clinical trial conducted in the United States, Peru and Chile. At the time of the
Storage Summary - Centers for Disease Control and …
www.cdc.gov211 1 Moderna COVID-19 Vaccine Storage and Handling Summary Basics Store vaccine in a freezer or refrigerator. See guidance below for each storage unit. Each box contains 10 multidose vials. See guidance below for each type of temperature monitoring Each multidose vial contains up to 15 doses. Each box is approximately 2 inches by 2 inches by 5.4 inches